Yves Heremans
Jette, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.
Journal: Diabetologia
Published: December 01, 2025
Transient ER stress cell-autonomously promotes beta cell cycling in mice.
Journal: Diabetologia
Published: September 25, 2025
Iron deficiency induces maturation-dependent loss of pancreatic β-cells.
Journal: Nature communications
Published: May 15, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.
Journal: Diabetologia
Published: November 21, 2024
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
Journal: Cancer research
Published: August 27, 2024
Harnessing beta cell regeneration biology for diabetes therapy.
Journal: Trends in endocrinology and metabolism: TEM
Published: February 03, 2024
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine.
Journal: Theranostics
Published: April 08, 2023
Axon guidance genes control hepatic artery development.
Journal: Development (Cambridge, England)
Published: February 03, 2023
Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Journal: Cells
Published: November 30, 2020
MECOM permits pancreatic acinar cell dedifferentiation avoiding cell death under stress conditions.
Journal: Cell death and differentiation
Published: July 20, 2020
Last Updated: 09/26/2026